tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $273.96. This is a potential upside of $271.91 (13263.9%) from yesterday's end of day stock price of $2.05.
Eiger Biopharmaceuticals's activity chart (see below) currently has 19 price targets and 24 ratings on display.
Analysts average stock forecasts to be materialized ratio is 11.11% with an average time for these price targets to be met of 32.67 days.
Most recent stock forecast was given by BRIAN SKORNEY from BAIRD on 30-Jun-2023. First documented stock forecast 24-Mar-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$0.95 (46.34%)
$3
1 years 8 months 9 days ago
(30-Jun-2023)
2/2 (100%)
$2.3 (328.57%)
294
Buy
2 years 2 months 27 days ago
(12-Dec-2022)
0/3 (0%)
$35.04 (351.81%)
Buy
2 years 3 months 2 days ago
(09-Dec-2022)
0/2 (0%)
$999.6 (243.57%)
Buy
$22
$19.95 (973.17%)
$34
4 years 3 months 14 days ago
(25-Nov-2020)
0/5 (0%)
$13.25 (151.43%)
Buy
$690
$687.95 (33558.54%)
$810
4 years 7 months 1 days ago
(10-Aug-2020)
0/2 (0%)
$317.4 (85.19%)
What is EIGR (Eiger Biopharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on EIGR (Eiger Biopharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on EIGR (Eiger Biopharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on EIGR (Eiger Biopharmaceuticals)?
Which analyst is the currently most bullish on EIGR (Eiger Biopharmaceuticals)?
Which analyst is the currently most reserved on EIGR (Eiger Biopharmaceuticals)?
